Cohance Lifesciences Surges 20% on Leadership Boost, Extends Sharp Recovery

Lifesciences witnessed a sharp rally on April 27, 2026, with its share price soaring 20% in today’s trade. The surge comes after the company announced the appointment of Umang Vohra as Executive Chairman and Group CEO, boosting investor sentiment. Notably, the stock has rebounded strongly, gaining nearly 62% from its 52-week low recorded on March 9, 2026. The sharp recovery highlights renewed interest in the counter, supported by leadership change and improving momentum in recent sessions. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.